&Partners’s Houlihan Lokey HLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.3M Sell
22,976
-363
-2% -$59.7K 0.02% 691
2025
Q4
$4.06M Buy
23,339
+8,095
+53% +$1.49M 0.02% 570
2025
Q3
$3.13M Buy
15,244
+844
+6% +$165K 0.02% 580
2025
Q2
$2.59M Sell
14,400
-294
-2% -$49.4K 0.02% 565
2025
Q1
$2.34M Buy
14,694
+3,815
+35% +$655K 0.02% 488
2024
Q4
$1.86M Buy
10,879
+3,242
+42% +$571K 0.02% 524
2024
Q3
$1.21M Buy
7,637
+4,274
+127% +$638K 0.02% 498
2024
Q2
$454K Buy
+3,363
New +$440K 0.02% 580

Other funds holding HLI

&Partners's HLI Position: Q1 2026 in Review

&Partners reduced its Houlihan Lokey (HLI) stake by 1.6% in Q1 2026, selling an estimated $59.7K and leaving 22,976 shares worth $3.3M. The position accounts for 0.02% of the portfolio, ranked #691.

&Partners first reported a position in HLI in Q2 2024 and has held it in 8 quarters since. The position peaked at $4.06M in Q4 2025. 544 funds tracked by Wall St. Rank hold HLI as of Q1 2026.

  • &Partners held 22,976 shares of Houlihan Lokey worth $3.3M as of Q1 2026.
  • &Partners sold 363 Houlihan Lokey shares in Q1 2026, an estimated $59.7K.
  • Houlihan Lokey made up 0.02% of &Partners's portfolio in Q1 2026, its #691 holding.
  • &Partners first reported a position in Houlihan Lokey in Q2 2024 and has held it in 8 quarters since.
  • &Partners's Houlihan Lokey position peaked at $4.06M in Q4 2025.
  • 544 funds tracked by Wall St. Rank held Houlihan Lokey as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.